15497909

Source:http://linkedlifedata.com/resource/pubmed/id/15497909

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0014939, umls-concept:C0033306, umls-concept:C0043210, umls-concept:C0076660, umls-concept:C0087111, umls-concept:C0205195, umls-concept:C0205210, umls-concept:C0278329, umls-concept:C1706907, umls-concept:C2603343
pubmed:issue	2
pubmed:dateCreated	2004-10-22
pubmed:abstractText	To describe and compare the history and clinical characteristics of women who were prescribed tibolone or one of the following combined estrogen + progestogen therapies (CEPT): sequential conjugated equine estrogens (CEE)/norgestrel, sequential CEE/medroxyprogesterone acetate (MPA), continuous CEE/MPA or continuous estradiol/norethisterone acetate (NETA).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9810959
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor Modulators, http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, Conjugated (USP), http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone Acetate, http://linkedlifedata.com/resource/pubmed/chemical/Norgestrel, http://linkedlifedata.com/resource/pubmed/chemical/Norpregnenes, http://linkedlifedata.com/resource/pubmed/chemical/tibolone
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1369-7137
pubmed:author	pubmed-author:Boerstoel-StreeflandMM, pubmed-author:HendricksP TPT, pubmed-author:WierikE J M Velthuis-teEJ
pubmed:issnType	Print
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	197-209
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:15497909-Breast Neoplasms, pubmed-meshheading:15497909-Drug Administration Schedule, pubmed-meshheading:15497909-Drug Therapy, Combination, pubmed-meshheading:15497909-Drug Utilization, pubmed-meshheading:15497909-Endometrial Neoplasms, pubmed-meshheading:15497909-Estradiol, pubmed-meshheading:15497909-Estrogen Receptor Modulators, pubmed-meshheading:15497909-Estrogen Replacement Therapy, pubmed-meshheading:15497909-Estrogens, Conjugated (USP), pubmed-meshheading:15497909-Female, pubmed-meshheading:15497909-Great Britain, pubmed-meshheading:15497909-Humans, pubmed-meshheading:15497909-Medroxyprogesterone Acetate, pubmed-meshheading:15497909-Middle Aged, pubmed-meshheading:15497909-Norgestrel, pubmed-meshheading:15497909-Norpregnenes, pubmed-meshheading:15497909-Physician's Practice Patterns, pubmed-meshheading:15497909-Registries, pubmed-meshheading:15497909-Retrospective Studies, pubmed-meshheading:15497909-Risk Factors
pubmed:year	2004
pubmed:articleTitle	Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study.
pubmed:affiliation	NV Organon, The Netherlands.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't